Research Article
Less Intensive Regimens May Still Be Suitable for the Initial Treatment of Primary Mediastinal B-Cell Lymphoma in Resource-Limited Settings
Table 2
Comparison among baseline characteristics of the three treatment groups.
| | DA-R-EPOCH (n = 39) | R-CHOP (n = 33) | R-CHOEP (n = 18) | -value |
| Sex (female, %) | 59 | 57.6 | 61.1 | 0.970 | Age (mean) | 30.3 | 36 | 30.1 | 0.073 | LDH (mean) | 3.29 | 2 | 2.44 | 0.035 | LDH (>2ULN, %) | 64.1 | 40.6 | 44.4 | 0.113 | Albumin (mean) | 3.7 | 4.1 | 4.03 | 0.023 | B-symptoms (%) | 74.4 | 80.6 | 72.2 | 0.753 | LMR (mean) | 1.48 | 2.12 | 1.44 | 0.110 | LMR (<1.3, %) | 53.8 | 36.4 | 52.9 | 0.291 | Thrombosis (%) | 38.5 | 32.3 | 41.2 | 0.794 | Advanced stage (%) | 53.8 | 25.8 | 44.4 | 0.06 | Bulky disease (%) | 92.3 | 90.3 | 93.8 | 0.912 | Cytoreductive COP (%) | 48.7 | 63.6 | 23.5 | 0.027 | R-IPI | | | | 0.21 | Very good | 6/39 (7.7%) | 4/29 (13.8%) | 2/20 (10%) | | Good | 22/39 (56.4%) | 12/29 (41.4%) | 12/20 (60%) | | Poor | 14/39 (35.9%) | 13/29 (44.8%) | 6/20 (30%) | | aaIPI | | | | 0.22 | Low | 3 (7.7%) | 4 (13.8%) | 2/20 (10%) | | Low-intermediate | 11 (28.2%) | 8 (27.6%) | 9 (45%) | | High-intermediate | 19 (48.7%) | 11 (37.9%) | 7 (35%) | | High | 6 (25.4%) | 6 (20.6%) | 2 (10%) | |
|
|